Jump to
Administrator Info
Name: Admin
Phone: 612-624-9996
Fax: 612-625-4410
Email: idimdivision@umn.edu
Mail: Mayo Memorial Building, MMC 250, 420 Delaware Street S.E., Minneapolis, MN 55455
Summary
Jo-Anne Young (née van Burik), M.D., is a Professor of Medicine and Medical Director of the Program in Adult Transplant Infectious Disease. She joined the faculty in 1999. She received both her B.A. and M.D. from Case Western Reserve University and completed a residency in Medicine at Vanderbilt University Medical Center. Her fellowship in Infectious Disease and several years of junior faculty service were at the University of Washington with the Fred Hutchinson Cancer Research Center. Dr. Young's primary area of interest is bringing diagnostic and treatment opportunities to the bedside for transplant patients. She has worked on developing diagnostic testing for complicated fungal infections of the immunocompromised host. Currently, Dr. Young is lead investigator at the University of Minnesota for multiple clinical trials on bacterial, viral, and fungal agents, as well as vaccines and a T cell prevention study, for transplant patients.
MD, Case Western Reserve University School of Medicine
Thompson, 3rd, G. R., Soriano, A., Cornely, O. A., Kullberg, B. J., Kollef, M., Vazquez, J., Honore, P. M., Bassetti, M., Pullman, J., Chayakulkeeree, M., Poromanski, I., Dignani, C., Das, A. F., Sandison, T., Pappas, P. G., Young, J. H. (2023). Rezafungin versus caspofungin for treatment of candidaemia and invasive candidiasis (ReSTORE): a multicentre, double-blind, double-dummy, randomised phase 3 trial. Lancet (London, England), 401(10370), 49-59. PMID: 36442484 doi: 10.1016/S0140-6736(22)02324-8,
Young, J. H. (Lead Author), El Jurdi, N., Rayes, A., MacMillan, M. L., Holtan, S. G., Cao, Q., Witte, J., Arora, M., Weisdorf, D. J. (2022). Steroid-Sensitive, but Not Steroid-Dependent or Steroid-Resistant Acute Graft-versus-Host Disease, Results in Similar Infection Risk as No Graft-versus-Host Disease following Allogeneic Hematopoietic Cell Transplantation. Transplantation and Cellular Therapy, 28(8), 509.e1-509.e11. PMID: 35577324 doi: 10.1016/j.jtct.2022.05.008,
Blumberg, E. A., Collins, G., Young, J. H., Nguyen, M. H., Michonneau, D., Temesgen, Z., Origȕen, J., Barcan, L., Obeid, K. M., Belloso, W. H., Gras, J., Corbelli, G. M., Neaton, J. D., Lundgren, J., Snydman, D. R., Molina, J. M.
(2022). Clostridioides difficile infection in solid organ and hematopoietic stem cell transplant recipients: A prospective multinational study. Transplant Infectious Disease: an official journal of the Transplantation Society, 24(1), e13770. PMID: 34821423 doi: 10.1111/tid.13770,
Kaplan, A., Young, J. H., Kandaswamy, R., Berglund, D., Knoll, B. M., Sieger, G., Cavert, W., Matas, A., Obeid, K. M. (2020). Long-Term Infectious and Noninfectious Outcomes of Monthly Alemtuzumab as a Calcineurin Inhibitor-and Steroid-Free Regimen for Pancreas Transplant Recipients. The Canadian journal of infectious diseases & medical microbiology = Journal canadien des maladies infectieuses et de la microbiologie medicale, 2020, 8883183. PMID: 33101558 PMCID: PMC7569440 doi: 10.1155/2020/8883183,
Castle Connolly Top Doctor, 2022
Best Doctors for Women, Minnesota Monthly, 2014
Best Doctor, Minnesota Monthly
Best Doctors in America
Clinical Microbiology Reviews, Immediate Past Editor-in-Chief
Transplantation and Cellular Therapy Journal, Associate Editor
Hope Act (use of organs from HIV+ donors into HIV+ recipients), DSMB member